About Ensemble

Scientific Founder

DAVID R. LIU, Ph.D.

Founder of Ensemble Therapeutics
Professor of Chemistry and Chemical Biology at Harvard University
Howard Hughes Medical Institute Investigator

Scientific Advisory Board

DAVID ARMISTEAD, Ph.D.

Entrepreneur-in-Residence at Third Rock Ventures
Co-founder of Kinetix Pharmaceuticals
Former VP and Site Head of the Amgen Cambridge Research Center

FRANCIS BARANY, Ph.D.

Professor, Department of Microbiology, Weill Cornell Medical College
Member of the joint Cornell/Sloan-Kettering Institute’s Molecular Biology Program

SIR SIMON CAMPBELL, CBE, FRS, FMedSci

Former SVP for Pfizer Worldwide Discovery and Medicinals R&D in Europe
Former President of the Royal Society of Chemistry

PAT CONFALONE, Ph.D.

Consultant to the biotechnology and pharmaceutical industry at Confalone Consulting
Previously VP Research & Development, DuPont Crop Protection and SVP Bristol-Myers Squibb

GERARD EVAN, Ph.D., FRS

Sir William Dunn Professor of Biochemistry and Head of Department of Biochemistry at the University of Cambridge
Previously Professor of Cancer Research at UCSF Helen Diller Family Comprehensive Cancer Center

MARK MURCKO, Ph.D.

SVP of Strategy at Schrödinger
Former VP, Chief Technology Officer and Chair of the Scientific Advisory Board of Vertex Pharmaceuticals

CRAIG A. SMITH, Ph.D.

Co-founder, VLST Scientific Fellow and Chairman of the Scientific Advisory Board of VLST Corporation

MICHAEL E. WEINBLATT, M.D.

Co-director of Clinical Rheumatology at the Brigham and Women’s Hospital
John R. Riedman Professor of Medicine at Harvard Medical School